Calendar Santhera Pharmaceuticals Holding AG OTC Markets

Equities

SPHDF

CH1276028821

Market Closed - OTC Markets 17:23:09 22/02/2024 GMT 5-day change 1st Jan Change
11.7 USD +4.00% Intraday chart for Santhera Pharmaceuticals Holding AG -.--% -.--%

Chart calendar Santhera Pharmaceuticals Holding AG

1a347535e52c27f502d75e.dWIA0qJ4VUW71hBTOO8h9WcSol3qNjrgjy31OR7OAto.GSxqoJAOLHPrjyUYV5tYr1dD2y3dew6zxhydAVeZe7gPKDa00T49Mc_ncw~b3726611fd8b73ff5d895e0a896617f7

Upcoming events on Santhera Pharmaceuticals Holding AG

03/09/2024 Q2 2024 Earnings Release (Projected)
23/04/2025 Q4 2024 Earnings Release (Projected)
02/09/2025 Q2 2025 Earnings Release (Projected)
22/04/2026 Q4 2025 Earnings Release (Projected)

Past events on Santhera Pharmaceuticals Holding AG

19/06/2024 13:00 Business Update Call
18/06/2024 09:00 Annual General Meeting
25/04/2024 13:30 Q4 2023 Earnings Call
25/04/2024 06:00 Q4 2023 Earnings Release
02/10/2023 World Muscle Society Congress
12/09/2023 15:00 H.C. Wainwright Global Investment Conference
07/09/2023 13:30 Q2 2023 Earnings Call
07/09/2023 06:00 Q2 2023 Earnings Release
02/07/2023 Reverse Split: 1 of 10
28/06/2023 PPMD Conference
27/06/2023 09:00 Annual General Meeting
27/04/2023 13:30 Q4 2022 Earnings Call
27/04/2023 06:00 Q4 2022 Earnings Release
18/03/2023 MDA Clinical & Scientific Conference
29/11/2022 09:30 Extraordinary Shareholders Meeting
07/11/2022 13:30 Interim 2022 Earnings Call
31/10/2022 06:00 Interim 2022 Earnings Release
14/10/2022 18:40 World Muscle Society Congress - Poster : #FP.27
14/10/2022 18:30 World Muscle Society Congress - Poster : #P.133
12/10/2022 20:00 World Muscle Society Congress - Poster : #P.71

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
75,4
76,1
-0.95%
15,0
15,0
0.05%
-1,60
8,00
-119.94%
7,47
0,00
-
103
8,29
1147%

24,0

EBITDA
Million CHF
Released
Forecast
Spread
-5,67
-1,92
-195.13%
-45,9
-42,0
-9.38%
-39,6
-25,0
-58.26%
-42,1
-35,0
-20.34%
0,00
0,00
-

-27,0

EBIT
Million CHF
Released
Forecast
Spread
-10,4
-5,30
-97.19%
-53,1
-51,5
-3.06%
-56,9
-29,0
-96.17%
-52,0
-39,0
-33.27%
68,8
-48,0
243.32%

-30,0

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-18,4
0,41
-4597.31%
-67,5
-62,5
-7.93%
-54,7
-39,0
-40.3%
-69,7
-47,0
-48.27%
0,00
0,00
-

-35,0

Net income
Million CHF
Released
Forecast
Spread
-19,0
0,41
-4738.88%
-67,7
-71,0
4.71%
-55,5
-39,0
-42.37%
-70,1
-47,0
-49.25%
0,00
0,00
-

-35,0

EPS
CHF
Released
Forecast
Spread
-17,3
0,37
-4775.68%
-50,8
-42,3
-20.09%
-16,2
-7,20
-125%
-11,7
-6,30
-85.71%
0,00
0,00
-

-2,81

Announcement Date24/03/2029/04/2110/06/2227/04/2325/04/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CHF
Released
Forecast
Spread

1,85


1,99


2,05


2,40


5,70


10,3


13,7


21,4

EBIT
Million CHF
Released
Forecast
Spread

-10,5


-11,5


-12,6


-13,5













Announcement Date--------

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SANN Stock
  4. SPHDF Stock
  5. Calendar Santhera Pharmaceuticals Holding AG